If you are deciding what to do with Sankyo stock right now, you are definitely not alone. The conversation around Sankyo has heated up in recent months and for good reason, especially if you have been ...

Masahiro Kato takes over as Managing Director, Oliver Appelhans appointed to Head of the European Specialty Business Unit MUNICH--(BUSINESS WIRE)--Today, Daiichi Sankyo Europe GmbH, the European ...

TOKYO, June 10 (Reuters) - Shares in Daiichi Sankyo <4568.T> have nearly halved from a year-ago peak when Japan's No.3 drug maker agreed to buy India's generic drug maker Ranbaxy Laboratories . The ...

Merck will pay Daiichi Sankyo $5.5 billion in the agreement, which has a total potential consideration of up to $22 billion. Daiichi Sankyo aims for at least $6 billion of revenue from its oncology ...

Narrow-moat Daiichi Sankyo's first-quarter earnings exceeded our expectations due to strong performance across its businesses, including Enhertu and Lixiana sales as well as its American Regent ...

Merck and Daiichi Sankyo agreed to jointly develop and commercialize three potential cancer treatments in a deal worth up to $22 billion. Merck and Daiichi Sankyo will develop and commercialize three ...

Oct 19 (Reuters) - Daiichi Sankyo 4568.T and Merck MRK.N have entered into an agreement worth up to $22 billion to develop and commercialize three of Daiichi Sankyo's DXd antibody drug conjugate (ADC) ...

ABU DHABI, 14th August, 2025 (WAM) – Emirates Global Aluminium, the largest industrial company in the United Arab Emirates and the world’s biggest ‘premium aluminium’ producer, today announced an ...